Aptar to Present at 41st Annual J.P. Morgan Healthcare Conference on January 12, 2023
AptarGroup, Inc. (NYSE: ATR), a leader in drug delivery and consumer product dispensing, will present at the 41st Annual J.P. Morgan Healthcare Conference on January 12, 2023, at 12:45 p.m. EST. Key executives, including President and CEO Stephan Tanda, will be present. The presentation will be accessible on the company's Investors page. Aptar operates globally, providing innovative solutions for various markets, including pharmaceuticals and beauty. The company is headquartered in Crystal Lake, Illinois, employing 13,000 staff across 20 countries.
- None.
- None.
A copy of the presentation will be made available on the Investors page at www.aptar.com.
About Aptar
Aptar is a global leader in the design and manufacturing of a broad range of drug delivery, consumer product dispensing and active material science solutions and services. Aptar’s innovative solutions and services serve a variety of end markets including pharmaceutical, beauty, personal care, home care, food and beverage. Using insights, proprietary design, engineering and science to create dispensing, dosing and protective technologies for many of the world’s leading brands, Aptar in turn makes a meaningful difference in the lives, looks, health and homes of millions of patients and consumers around the world. Aptar is headquartered in
This press release contains forward-looking statements. Expressions or future or conditional verbs such as “will” are intended to identify such forward-looking statements. Forward-looking statements are made pursuant to the safe harbor provisions of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934 and are based on our beliefs as well as assumptions made by and information currently available to us. Accordingly, our actual results may differ materially from those expressed or implied in such forward-looking statements due to known or unknown risks and uncertainties that exist in our operations and business environment including, but not limited to: the successful integration of acquisitions; the regulatory environment; and competition, including technological advances. For additional information on these and other risks and uncertainties, please see our filings with the
View source version on businesswire.com: https://www.businesswire.com/news/home/20221221005535/en/
Investor Relations Contact:
Mary.skafidas@aptar.com
+1 347-351-6407
Media Contact:
katie.reardon@aptar.com
+1 815-479-5671
Source:
FAQ
What is AptarGroup's stock symbol and when is their presentation at the J.P. Morgan Healthcare Conference?
Who are the key executives presenting at the conference for AptarGroup?
Where can I find the presentation made by AptarGroup at the J.P. Morgan Healthcare Conference?
What markets does AptarGroup serve with its products and services?